Chinese companies have received Indian orders for more than 70,000 oxygen concentrators (representative) Beijing: China said on Friday that the prices of some of the COVID-19 medical supplies, such as oxygen concentrators bought by Indian companies from Chinese manufacturers, have risen as they have had to import raw materials fromRead More →

Global sourcing should not depend on the purely commercial prerogatives and exclusive rights of the pharmaceutical companies holding the technology. Defending the protection of monopolies contradicts your previous call that COVID-19 medical products be treated as global public goods; a call to which you have been joined by other headsRead More →